Comparative Efficacy and Safety of 4 Randomized Regimens to Treat EarlyPseudomonas aeruginosaInfection in Children With Cystic Fibrosis
Author(s) -
Miriam M. Treggiari,
George RetschBogart,
Nicole Mayer-Hamblett,
Umer Khan,
Michal Kulich,
Richard Kronmal,
Judy Williams,
Peter Hiatt,
Ronald L. Gibson,
Terry Spencer,
David M. Orenstein,
Barbara A. Chatfield,
Deborah Froh,
Jane L. Burns,
Margaret Rosenfeld,
Bonnie W. Ramsey
Publication year - 2011
Publication title -
archives of pediatrics and adolescent medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3628
pISSN - 1072-4710
DOI - 10.1001/archpediatrics.2011.136
Subject(s) - medicine , tobramycin , cystic fibrosis , randomized controlled trial , hazard ratio , exacerbation , ciprofloxacin , pseudomonas aeruginosa , odds ratio , placebo , confidence interval , antibiotics , surgery , microbiology and biotechnology , pathology , genetics , alternative medicine , bacteria , biology
To investigate the efficacy and safety of 4 antipseudomonal treatments in children with cystic fibrosis with recently acquired Pseudomonas aeruginosa infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom